scholarly article | Q13442814 |
P50 | author | Daniel Abebayehu | Q87091461 |
Carole A Oskeritzian | Q87091469 | ||
P2093 | author name string | John J Ryan | |
Bianca Baker | |||
Brian O Barnstein | |||
Alena P Chumanevich | |||
Amina Abdul Qayum | |||
Andrew J Spence | |||
Anuya Paranjape | |||
Jamie Josephine Avila McLeod | |||
Marcela T Taruselli | |||
Gurjas S Bajaj | |||
Oksana Chernushevich | |||
P2860 | cites work | IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 |
Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. | Q24537701 | ||
Development, migration, and survival of mast cells | Q24549674 | ||
Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor | Q24561876 | ||
The role of IL-33 and mast cells in allergy and inflammation | Q26783420 | ||
Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo | Q28345893 | ||
Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 | Q28366337 | ||
Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells | Q28571913 | ||
Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway | Q28587516 | ||
Molecular mechanisms of spontaneous and directed mast cell motility | Q30525710 | ||
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation | Q33651095 | ||
Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. | Q33895733 | ||
IL-33/ST2 axis promotes mast cell survival via BCLXL. | Q33925929 | ||
The IL-33/ST2 pathway: therapeutic target and novel biomarker | Q34776884 | ||
Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33 | Q34895161 | ||
IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. | Q35036030 | ||
IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk | Q35565295 | ||
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo | Q35575987 | ||
Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects. | Q36553647 | ||
IL-33 exacerbates antigen-induced arthritis by activating mast cells | Q36800502 | ||
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells | Q36990456 | ||
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria | Q37273100 | ||
Role of IL-33 in inflammation and disease | Q37922810 | ||
IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. | Q38256319 | ||
Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. | Q39457701 | ||
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid | Q39947300 | ||
Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone | Q40795700 | ||
The thrombogenic hypothesis and its implications | Q40831957 | ||
Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells | Q41167760 | ||
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. | Q41468527 | ||
Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells | Q42522030 | ||
FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration | Q42569152 | ||
Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma | Q42981972 | ||
IL-33 exacerbates autoantibody-induced arthritis | Q43170043 | ||
Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes | Q43551017 | ||
Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase | Q43699080 | ||
Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent | Q44427614 | ||
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. | Q48240026 | ||
Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. | Q51660722 | ||
Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. | Q53085315 | ||
Interleukin-10-producing CD5+ B cells inhibit mast cells during immunoglobulin E-mediated allergic responses. | Q53579877 | ||
IL-33 induces skin inflammation with mast cell and neutrophil activation | Q57231942 | ||
IL-33 can promote survival, adhesion and cytokine production in human mast cells | Q57273112 | ||
Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids | Q67918527 | ||
Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse | Q72412489 | ||
Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells | Q77484047 | ||
Studies on dexamethasone, a new synthetic steroid, in rheurheumatoid arthritis: a preliminary report; adrenal cortical, metabolic and early clinical effects | Q78266115 | ||
A decade of anti-inflammatory steroids, from cortisone to dexamethasone. Summary | Q79178610 | ||
P433 | issue | 6 | |
P921 | main subject | mast cell | Q191989 |
dexamethasone | Q422252 | ||
P304 | page(s) | 1395-1404 | |
P577 | publication date | 2016-07-21 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity | |
P478 | volume | 100 |
Q61796660 | A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia |
Q54213225 | Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today. |
Q45064301 | Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells. |
Q45068864 | Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription |
Q88452579 | Efficacy of long-term intralesional triamcinolone in Morbihan's disease and its possible association with mast cell infiltration |
Q50193724 | Involvement of the Negative Feedback of IL-33 Signaling in the Anti-Inflammatory Effect of Electro-acupuncture on Allergic Contact Dermatitis via Targeting MicroRNA-155 in Mast Cells |
Q90884836 | Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps |
Search more.